Synthesis and crystallographic analysis of two rhizopuspepsin inhibitor complexes.
暂无分享,去创建一个
D. Davies | K. Parris | D J Hoover | D R Davies | D B Damon | K D Parris | D. Hoover | D. B. Damon
[1] John P. Overington,et al. X-ray analysis of HIV-1 proteinase at 2.7 Å resolution confirms structural homology among retroviral enzymes , 1989, Nature.
[2] D. Rich,et al. Pepstatin binding to pepsin. Enzyme conformation changes monitored by nuclear magnetic resonance. , 1982, Biochemistry.
[3] Brian W. Matthews,et al. Structural basis of the action of thermolysin and related zinc peptidases , 1988 .
[4] A Wlodawer,et al. Structure at 2.5-A resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene-based inhibitor. , 1991, Biochemistry.
[5] T. Blundell,et al. X-ray analyses of aspartic proteinases. The three-dimensional structure at 2.1 A resolution of endothiapepsin. , 1994, Journal of molecular biology.
[6] M. Karplus,et al. Dynamics of ligand binding to heme proteins. , 1979, Journal of molecular biology.
[7] C. Abad-Zapatero,et al. Revised 2.3 Å structure of porcine pepsin: Evidence for a flexible subdomain , 1990, Proteins.
[8] E. Meyer,et al. X-ray diffraction analysis of the inhibition of porcine pancreatic elastase by a peptidyl trifluoromethylketone. , 1988, Journal of molecular biology.
[9] D. Davies,et al. The structure and function of the aspartic proteinases. , 1990 .
[10] T. A. Jones,et al. A graphics model building and refinement system for macromolecules , 1978 .
[11] W. Watt,et al. Design and synthesis of potent and specific renin inhibitors containing difluorostatine, difluorostatone, and related analogues. , 1986, Journal of medicinal chemistry.
[12] Maria Miller,et al. Crystal structure of a retroviral protease proves relationship to aspartic protease family , 1989, Nature.
[13] J Cooper,et al. The structure of a synthetic pepsin inhibitor complexed with endothiapepsin. , 1987, European journal of biochemistry.
[14] J. Finn,et al. A widely useful chiral stationary phase for the high-performance liquid chromatography separation of enantiomers , 1981 .
[15] D. Rich,et al. Synthesis of (3S,4S)-4-amino-3-hydroxy-6-methylheptanoic acid derivatives. Analysis of diastereomeric purity , 1978 .
[16] T L Blundell,et al. X-ray analyses of aspartic proteinases. III Three-dimensional structure of endothiapepsin complexed with a transition-state isostere inhibitor of renin at 1.6 A resolution. , 1990, Journal of molecular biology.
[17] M. James,et al. Stereochemical analysis of peptide bond hydrolysis catalyzed by the aspartic proteinase penicillopepsin. , 1985, Biochemistry.
[18] D. Rich,et al. Direct carbon-13 NMR evidence for a tetrahedral intermediate in the binding of a pepstatin analog to porcine pepsin , 1982 .
[19] Michael H. Gelb,et al. Crystallographic analysis of transition state mimics bound to penicillopepsin: difluorostatine- and difluorostatone-containing peptides. , 1994 .
[20] L. Polgár. The mechanism of action of aspartic proteases involves ‘push‐pull’ catalysis , 1987, FEBS letters.
[21] M. Gelb,et al. Fluoro ketone inhibitors of hydrolytic enzymes. , 1985, Biochemistry.
[22] T. Lin,et al. Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine. , 1985, Journal of medicinal chemistry.
[23] A. Cunningham,et al. Effect of secondary substrate binding in penicillopepsin: contributions of subsites S3 and S2' to kcat. , 1988, Biochemistry.
[24] J. Fried,et al. 2,2-Difluoro-3-hydroxyesters by reformatskii reaction , 1984 .
[25] K. Fearon,et al. Fluoro ketone containing peptides as inhibitors of human renin. , 1987, Journal of medicinal chemistry.
[26] T L Blundell,et al. Domain flexibility in aspartic proteinases , 1992, Proteins.
[27] F. Salituro,et al. Pepsin-catalysed addition of water to a ketomethylene peptide isostere: observation of the tetrahedral species by 13C-nuclear-magnetic-resonance spectroscopy. , 1985, Biochemical Society Transactions.
[28] W A Hendrickson,et al. Influence of solvent accessibility and intermolecular contacts on atomic mobilities in hemerythrins. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[29] S. Bizzozero,et al. Stereochemical aspects of peptide hydrolysis catalyzed by serine proteases of the chymotrypsin type , 1981 .
[30] G. Cohen,et al. Structure and refinement at 1.8 A resolution of the aspartic proteinase from Rhizopus chinensis. , 1987, Journal of molecular biology.
[31] Tom Blundell,et al. The active site of aspartic proteinases , 1991, FEBS letters.
[32] T. Hofmann,et al. Rate‐determining steps in penicillopepsin‐catalysed reactions , 1990, FEBS letters.
[33] B. Finzel. Incorporation of fast Fourier transforms to speed restrained least‐squares refinement of protein structures , 1987 .
[34] T L Blundell,et al. Direct observation by X‐ray analysis of the tetrahedral “intermediate” of aspartic proteinases , 1992, Protein science : a publication of the Protein Society.
[35] M. Jaskólski,et al. Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. , 1989, Science.
[36] M. Dewar,et al. Mechanism of the chain extension step in the biosynthesis of fatty acids. , 1988, Biochemistry.
[37] S. Sheriff. Addition of symmetry‐related contact restraints to PROTIN and PROLSQ , 1987 .
[38] T. L. Blundell,et al. High resolution X-ray analyses of renin inhibitor-aspartic proteinase complexes , 1987, Nature.
[39] A. Fedorov,et al. Molecular and crystal structures of monoclinic porcine pepsin refined at 1.8 A resolution. , 1990, Journal of molecular biology.
[40] R. C. Agarwal. A new least‐squares refinement technique based on the fast Fourier transform algorithm: erratum , 1978 .
[41] W. Kati,et al. Difluorostatine- and difluorostatone-containing peptides as potent and specific renin inhibitors. , 1985, Journal of medicinal chemistry.
[42] T. Blundell,et al. High‐resolution X‐ray diffraction study of the complex between endothiapepsin and an oligopeptide inhibitor: the analysis of the inhibitor binding and description of the rigid body shift in the enzyme. , 1989, The EMBO journal.
[43] M. Navia,et al. Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1 , 1989, Nature.
[44] M. James,et al. Structure and refinement of penicillopepsin at 1.8 A resolution. , 1983, Journal of molecular biology.
[45] J. Kraut,et al. Subtilisin; a stereochemical mechanism involving transition-state stabilization. , 1972, Biochemistry.
[46] M. James,et al. Conformational flexibility in the active sites of aspartyl proteinases revealed by a pepstatin fragment binding to penicillopepsin. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[47] A. Berger,et al. On the size of the active site in proteases. I. Papain. , 1967, Biochemical and biophysical research communications.
[48] S. Creighton,et al. Enzymes work by solvation substitution rather than by desolvation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[49] P. Deslongchamps. Stereoelectronic control in the cleavage of tetrahedral intermediates in the hydrolysis of esters and amides , 1975 .
[50] M. L. Connolly. Analytical molecular surface calculation , 1983 .
[51] V. Kostka. Aspartic proteinases and their inhibitors : proceedings of the FEBS advanced course no. 84/07, Prague, Czechoslovakia, August 20-24, 1984 , 1985 .
[52] E. Padlan,et al. Binding of a reduced peptide inhibitor to the aspartic proteinase from Rhizopus chinensis: implications for a mechanism of action. , 1987, Proceedings of the National Academy of Sciences of the United States of America.